HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Ancora Heart and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients

Mark Miles, chief commercial officer of Ancora Heart. “This partnership with egnite and The Christ Health Network will allow us to deploy AI tools such as egnite’s Trial Accelerator and expedite identification of eligible candidates for the CORCINCH-HF trial.”

Study Links “Stuck” Stem Cells to Hair Turning Gray

The researchers found that as hair ages, sheds, and then repeatedly grows back, increasing numbers of McSCs get stuck in the stem cell compartment called the hair follicle bulge. There, they remain, do not mature into the transit-amplifying state, and do not travel back to their original location in the germ compartment, where WNT proteins would have prodded them to regenerate into pigment cells.

Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis

Data shows the achievement of the primary endpoint of decreasing esophageal intraepithelial eosinophil count and the positive impact on an array of histological measures of EoE. Favorable safety and tolerability profile consistent with Phase 1 trial results.

Exai Bio To Present New Non-Small Cell Lung Cancer Early Detection Data at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Exai Bio notes the findings demonstrate highly sensitive and specific detection of the earliest and smallest tumors using Exai’s novel RNA- and AI-based liquid biopsy platform.

Life Spine Releases Published Article on the Effect of Expandable Versus Static Lordotic Interbody Implants in Minimally Invasive Spine Surgery

Life Spine notes: The paper assessed the results of 100 patients who underwent transforaminal lumbar spinal fusion via minimally invasive surgery at L4-L5 or L5-S1. The objective of the paper was to see how the ProLift® Expandable Spacer System affected patient reported outcomes, sagittal alignment, and restoration of disc height and foraminal height comparative to static interbody cages.

Monteris Medical Announces Publication of Largest Series of NeuroBlate Laser Interstitial Thermal Therapy for Biopsy-Proven Radiation Necrosis

The largest prospectively-gathered dataset, collected through the company's LAANTERN (Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System) multi-center study and comprised of 90 patients with biopsy-proven RN, showed that LITT with NeuroBlate is a safe and highly effective minimally invasive option for the treatment of RN.

Assessing the Cardiac Risks of Cobalt in Hip Replacements

Some hip replacements can contain Cobalt and could potentially affect heart function in some patients. The study has also identified, for the first time, a link between cobalt-induced changes in calcium levels in heart muscle cells and reduced contraction of the heart.

Attune Medical and Heart Rhythm Clinical Research Solutions (HRCRS) Collaborate with Real World Evidence Consortium Members to Evaluate ensoETM™ in High Volume Centers

HRCRS will conduct a multi-center observational study through the RWE network of high-volume cardiac electrophysiology centers to collect data on the ensoETM’s effect on throughput and patient outcomes notes Attune Medical.

Blue Spark Technologies to Present New Standard of Care for Temperature Monitoring at HIMSS 2023

John Gannon, president and CEO, Blue Spark Technologies. “Where time is critical, continuous temperature monitoring with TempTraq helps clinicians take immediate action the moment that temperature spikes.”